Investing
Wednesday Afternoon's Top Analyst Upgrades and Downgrades: Coupang, Foot Locker, Gap, Stitch Fix and More
Published:
Markets bounced back with a vengeance on Wednesday, as the Nasdaq led the charge with a gain of over 2%. At the same time, oil prices pulled back from their 14-year highs in response to markets pushing higher. Investors are still weighing the ramifications of what trade sanctions with Russia might mean in the coming months, if not years.
24/7 Wall St. is reviewing some big analyst calls seen on Wednesday. We have included the latest call on each stock, as well as a recent trading history and the consensus targets among analysts. Note that analyst calls seen earlier in the day were on AMD, Dollar Tree, Kohl’s, Netflix, Palantir and many more.
Bumble Inc. (NASDAQ: BMBL): BMO Capital Markets upgraded the stock from Market Perform to Outperform with a $48 price target. The 52-week trading range is $15.92 to $76.49, and shares were trading near $24 Wednesday.
Coupang Inc. (NYSE: CPNG): UBS raised its Neutral rating to Buy. The 52-week trading range is $16.61 to $69.00, and shares were trading near $22 apiece on Wednesday.
Foot Locker Inc. (NYSE: FL): Argus’s downgrade was to Hold from Buy. Shares were trading near $30 on Wednesday. The 52-week range is $26.36 to $66.71.
Gap Inc. (NYSE: GPS): Daiwa Securities downgraded it to Underperform from Neutral and has a $13.75 price target. Shares were trading near $14 on Wednesday. The 52-week range is $13.12 to $37.63.
Match Group Inc. (NASDAQ: MTCH): BMO Capital Markets downgraded the shares to Market Perform from Outperform and has a $130 price target. Shares were trading near $96 on Wednesday. The 52-week range is $89.15 to $182.00.
Nektar Therapeutics (NASDAQ: NKTR): Oppenheimer’s upgrade was from Perform to Outperform with a $21 price target. The stock was trading near $11 on Wednesday, and the 52-week range is $9.31 to $23.50.
Paychex Inc. (NASDAQ: PAYX): BofA Securities lifted its Underperform rating to Neutral with a $125 price target. Shares were trading near $120. The 52-week range is $92.74 to $138.97.
Signify Health Inc. (NYSE: SGFY): UBS raised its $20 price target to $21 as it upgraded the stock to Buy from Neutral. The stock was trading around $17 on Wednesday, and the 52-week range is $11.11 to $31.91.
Stitch Fix Inc. (NASDAQ: SFIX): The Telsey Advisory downgrade to Market Perform from Outperform included a price target cut to $14 from $25. Truist also downgraded it, from Buy to Hold with a $12 price target. The 52-week trading range is $8.82 to $69.20, and shares were trading near $9 apiece Wednesday.
24/7 Wall St.Given recent geopolitical events, Goldman Sachs notes that vigilance at every level is now a huge priority to ensure cybersecurity and that six top companies will benefit from the increased spending across the industry.
Are You Ahead, or Behind on Retirement?
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: am I ahead, or behind on my goals?
Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With Zoe Financial’s free matching tool, you can connect with trusted financial advisors in minutes.
Why wait? Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.